The two-week reassessment is the operational habit I would keep if I had to give up every other one. I tell patients plainly: I can add more, but I can't take away. So I treat conservatively, and I bring them back.
The clinical reasoning for that interval — what is actually assessable at two weeks and what is still settling — belongs in its own piece and is covered elsewhere in this programme. This one is about the other half, the half that quietly determines whether the review ever happens: how you build it into the calendar, the pricing model, the consent conversation and the chart so that it is a policy rather than a favour.
Most injectors I meet believe in the two-week review. Far fewer have a system that produces one. That gap is entirely operational, and it is fixable in an afternoon.
Why "offered" is not the same as "booked"
There are two versions of this, and they are not variations on a theme. They are different products.
Version one: at the end of the appointment you say, if anything isn't quite right, give us a call and come back in. What happens next is predictable. Most patients do not call. The ones who do call at four or six weeks, once they have decided something is wrong, by which point the useful window for adding has narrowed and the conversation starts from dissatisfaction. And the appointment they eventually get reads to them as a remedy for a problem — which means the existence of the appointment implies something went wrong.
Version two: before the patient leaves the room, the review is on the calendar with a date and a time, described as a normal part of the treatment. Nothing is implied about the result. It is simply how the treatment works in your practice.
The clinical content of the two appointments is identical. The patient's experience of them is completely different, and so is the show rate.
The principle underneath is that a conservative first pass only works if the second pass reliably exists. Conservative dosing without a scheduled review is not conservatism, it is under-treatment. The two halves are a single decision, and if you are only going to implement one of them, implement the booking.
The language, which matters more than it should
Three words to standardise across your whole team, because patients take their interpretation from whatever the front desk says.
Call it a review, or a reassessment. Not a touch-up. Touch-up implies a repair, and a repair implies an error. Not a follow-up either, which in most people's vocabulary means "in case of a problem." Review is neutral and accurate: you are looking at the result and deciding whether the plan is complete.
Describe it as part of the treatment, not as an extra. Your treatment has two visits: today, and a review in two weeks. One sentence, said at the consultation rather than at the door, and it does most of the work.
Never describe it as a guarantee. This matters legally as well as ethically. A policy of reviewing every patient is a description of your process. It is not a promise about the outcome, and it must never be written or spoken in a way that implies a satisfaction or results guarantee. Keep the language on what you will do — look, assess, discuss — and off what the patient will get.
That framing should also appear in your written materials. Consent documentation is the natural place for it, alongside everything else the patient is agreeing to; our guide to what belongs in injectable consent forms covers the surrounding structure.
The calendar mechanics
Book it in the room, not at the desk. The handoff is where bookings die. If your system allows the treating clinician to book, book before the patient stands up. If it does not, walk the patient to the desk and say the date out loud.
Create a distinct appointment type. Not a generic slot. A named, short appointment type — ten to fifteen minutes is enough for most reviews — so that you can count them, report on them, and protect them from being filled with something longer.
Reserve the slots structurally. This is the part practices get wrong. If you treat twenty injectable patients in a week, then in steady state you need roughly twenty short slots two weeks later, every week, permanently. Those slots do not appear by accident. Block a recurring window — a short clinic on a fixed afternoon, for instance — and let bookings fill it. Practices that try to squeeze reviews into gaps end up with no gaps, and the policy quietly dies within a quarter.
Confirm at ten days. A two-week appointment booked two weeks ago has a higher no-show rate than a next-day appointment. One confirmation touch a few days ahead recovers most of that.
Decide the no-show rule before you need it. My position is that the review is part of the treatment episode, so a missed review gets one outreach and then a note in the chart recording that it was offered, scheduled and not attended. That note is worth having. What you should not do is let a missed review silently close the episode with no record that it existed.
The economics, honestly
The objection I hear most often is that this is a free appointment the practice cannot afford. Three responses.
It is not a free appointment, it is an unbilled portion of a billed episode. The relevant question is not whether you charge for the review; it is whether your treatment pricing reflects the fact that the treatment includes two visits. Practices that build the episode into the price do not experience the review as a loss. Practices that price a single visit and then absorb a second one do, and correctly.
Staged dosing changes the product economics. A conservative first pass does not consume the full quantity the patient might ultimately need. Whether the balance at the review is included or billed is a pricing-model decision — and it is a decision, not an accident. Make it explicitly, apply it consistently, and tell the patient at the consultation which model you use so there is no surprise at the second visit. Whatever model you choose, it should be the same for every patient.
The slot is short and the conversion is high. A ten-minute review with a satisfied patient two weeks after a good result is the single best-positioned conversation in aesthetic practice for planning what comes next. That is not the reason to do it — the reason is that you can add and cannot take away — but it is why the appointment is not the cost centre it looks like on a spreadsheet.
Against all of that, set the alternative. An unreviewed patient who is unhappy at six weeks costs a longer appointment, possibly a correction, sometimes a dissolution with its own time and consequences, and a relationship that never fully recovers. The review is cheap insurance against an expensive event.
What actually happens in the ten minutes
Operationally, four things, in this order.
Photographs first, before conversation. Same conditions, same views, same lighting as baseline. Standardised clinical photography is a discipline of its own and is covered in its own resource in this programme; the operational point here is simply that the images are taken before anyone discusses the result, so that the record is not influenced by the discussion.
Ready to put this into practice?
Explore Empire's hands-on, CME-accredited Aesthetic & Injectable Training courses — live patients, expert faculty, and ongoing mentorship.
Assessment by the treating clinician. Photography and rooming can be delegated. The assessment cannot. The person who made the plan is the person who can tell whether it did what it was designed to do.
A decision, recorded. One of three: complete, add, or watch. Write which one and why.
Closure of the episode, or a date. If the answer is complete, say so and close the note. If the answer is add, do it or book it. If the answer is watch, book the next point.
The commonest outcome is complete — nothing to change. That is the expected result, not a wasted appointment, and it is worth saying to your team so nobody starts treating the empty review as a failure of the system.
What goes in the chart
The review note is what makes your own practice reviewable six months later. At minimum: the date, the photographs, the finding, the decision, any additional product with quantity and plane, and the patient's own report. For toxin cases, also record onset and distribution as the patient describes them, because that is the information that refines the next plan — our reference on dosing the forehead and frontalis is the kind of decision that gets better when the previous review note is specific.
A treatment record without a review note is a record of what you did. A treatment record with one is a record of what happened.
This reflects Melissa Pulcini-Buttine's clinical practice as taught in Empire Medical Training's hands-on curriculum. Technique is learned under supervision; this article is educational and is not a substitute for training.
Variations worth planning for
Patients who travel. A distance patient may not be able to return at two weeks. Set up a structured remote review instead — standardised photographs taken to your specification, at the same interval, with a short call. It is not as good as an in-person assessment and you should say so, but it is much better than nothing and it preserves the discipline.
Established patients on a repeat plan. Once you have reviewed a patient through a full cycle and know how they respond, the interval can be a clinical judgement rather than a fixed rule. Change it deliberately and record that you did.
New patients, new products, new regions. No exceptions. Anything you have not done before in this face gets the full review.
What changes on Monday
Create the appointment type today. Name it review.
Block the recurring capacity for it before you promise it to anyone, because a policy you cannot staff is worse than no policy.
Move the booking into the treatment room and out of the reception queue.
Standardise the sentence — your treatment has two visits — and have everyone on the team say the same one.
And write your pricing model down, so that the second visit is never a negotiation.
Conservative dosing plus a scheduled review is a system, not a preference. Empire's Complete Botox Training and Complete Facial Aesthetic Training teach the treatment planning that the review is built around.
About the author. Melissa Pulcini-Buttine, PA, has practised as a physician assistant for two decades and has taught anatomy and physiology for approximately fourteen years. She is a faculty member at Empire Medical Training and the founder of an aesthetics practice in Greenwich, Connecticut.
Frequently Asked Questions
Should the two-week review be booked or offered?
Booked, in the treatment room, before the patient leaves. An offered review depends on the patient deciding something is wrong and calling, which most do not do until the useful window has narrowed. A booked review is part of the treatment; an offered one reads as a remedy for a problem.
How do I find the capacity for a review on every patient?
Reserve it structurally rather than fitting it into gaps. In steady state you need roughly as many short review slots per week as you have treatment patients, two weeks later. Create a distinct ten-to-fifteen-minute appointment type and block a recurring window for it, then let bookings fill that window.
Should I charge for a two-week reassessment?
That is a pricing-model decision rather than a clinical one, and the key is consistency. Practices that price the treatment as a two-visit episode do not experience the review as a loss. Whichever model you use, apply it to every patient and explain it at the consultation so the second visit is never a negotiation.
What should I call the appointment?
A review or a reassessment. Avoid "touch-up," which implies a repair, and avoid "follow-up," which most patients interpret as being for problems only. Standardise the term across the clinical team and the front desk so the patient hears the same description at every point.
Can I describe my review policy in patient communications?
You can describe the process — that every treatment includes a review visit at two weeks. You must not frame it as a satisfaction or results guarantee, in writing or in conversation. Keep the language on what you will do at the visit, never on what the patient is assured of receiving.
Disclaimer
This article reflects the clinical opinions and experience of Melissa Pulcini-Buttine, PA, an independent faculty member contributing to Empire Medical Training's curriculum. The views expressed are the author's own and do not necessarily represent those of Empire Medical Training.
It is professional education, not medical advice, and is no substitute for hands-on training or independent clinical judgment. Licensed clinicians remain responsible for their own patient selection, technique and outcomes, for verifying current product labelling, and for practising within their scope and applicable law. Empire Medical Training accepts no liability for reliance on this content.
